🇺🇸 FDA
Patent

US 9545422

Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells

granted A61KA61K31/713A61K38/177

Quick answer

US patent 9545422 (Methods of inducing photosensitivity by targeting channelrhodopsin-2 and halorhodopsin to subcellular regions of retinal ganglion cells) held by The Regents of the University of California expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/713, A61K38/177, A61K38/1796, A61K45/06